Top 5 Medical Stocks To Own For 2019

Massachusetts Financial Services Co. MA trimmed its holdings in shares of Zimmer Biomet (NYSE:ZBH) by 8.5% during the first quarter, HoldingsChannel reports. The institutional investor owned 15,053,800 shares of the medical equipment provider’s stock after selling 1,404,161 shares during the quarter. Massachusetts Financial Services Co. MA owned 0.07% of Zimmer Biomet worth $1,641,467,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the business. Longview Partners Guernsey LTD boosted its holdings in shares of Zimmer Biomet by 6.9% during the 4th quarter. Longview Partners Guernsey LTD now owns 8,027,808 shares of the medical equipment provider’s stock worth $968,716,000 after buying an additional 521,124 shares in the last quarter. American Century Companies Inc. boosted its holdings in shares of Zimmer Biomet by 5.5% during the 1st quarter. American Century Companies Inc. now owns 5,039,181 shares of the medical equipment provider’s stock worth $549,472,000 after buying an additional 261,784 shares in the last quarter. OppenheimerFunds Inc. boosted its holdings in shares of Zimmer Biomet by 14.8% during the 4th quarter. OppenheimerFunds Inc. now owns 2,644,596 shares of the medical equipment provider’s stock worth $319,124,000 after buying an additional 340,845 shares in the last quarter. Wells Fargo & Company MN boosted its holdings in shares of Zimmer Biomet by 13.1% during the 1st quarter. Wells Fargo & Company MN now owns 2,312,443 shares of the medical equipment provider’s stock worth $252,149,000 after buying an additional 268,068 shares in the last quarter. Finally, Geode Capital Management LLC boosted its holdings in shares of Zimmer Biomet by 4.9% during the 4th quarter. Geode Capital Management LLC now owns 2,175,052 shares of the medical equipment provider’s stock worth $261,927,000 after buying an additional 101,575 shares in the last quarter. Hedge funds and other institutional investors own 86.62% of the company’s stock.

Top 5 Medical Stocks To Own For 2019: Avery Dennison Corporation(AVY)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:

    Get Avery Dennison alerts:

    Avery Dennison (AVY) Shares Cross Below 200 DMA (nasdaq.com) Avery Dennison (AVY) Given Average Rating of “Buy” by Brokerages (americanbankingnews.com) Concern in Framingham about environmental contamination (metrowestdailynews.com) Avery Dennison (AVY) Rating Lowered to Hold at Zacks Investment Research (americanbankingnews.com) Avery Dennison (AVY) Upgraded at Zacks Investment Research (americanbankingnews.com)

    Several equities research analysts recently commented on AVY shares. Citigroup dropped their price objective on Avery Dennison from $140.00 to $125.00 and set a “buy” rating on the stock in a research report on Thursday, April 5th. Zacks Investment Research raised Avery Dennison from a “hold” rating to a “buy” rating and set a $132.00 price objective on the stock in a research report on Monday, February 5th. UBS started coverage on Avery Dennison in a research report on Thursday, January 18th. They set a “buy” rating and a $135.00 price objective on the stock. Bank of America increased their price objective on Avery Dennison from $128.00 to $133.00 and gave the company a “buy” rating in a research report on Thursday, February 1st. Finally, KeyCorp reaffirmed a “hold” rating on shares of Avery Dennison in a research report on Wednesday, April 25th. Five research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $123.00.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
    Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
    Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million.
    Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion.
    General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion.
    The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion.
    Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion.
    Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion.
    Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion.
    Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion.
    Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion.
    The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion.
    Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion.
    T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion.
    Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion.
    Sirius XM Holdings Inc. (NASDAQ: SI
  • [By Stephan Byrd]

    Strategy Asset Managers LLC acquired a new stake in Avery Dennison (NYSE:AVY) during the first quarter, HoldingsChannel.com reports. The firm acquired 23,500 shares of the industrial products company’s stock, valued at approximately $2,497,000.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Avery Dennison (AVY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Medical Stocks To Own For 2019: Cidara Therapeutics, Inc.(CDTX)

Advisors’ Opinion:

  • [By Chris Lange]

    Cidara Therapeutics Inc. (NASDAQ: CDTX) shares took a big step back on Monday, despite the firm reporting positive midstage results. Specifically, Cidara reported positive topline results from its Phase 2 Strive clinical trial of its lead antifungal candidate rezafungin acetate.

  • [By Joseph Griffin]

    Cidara Therapeutics (NASDAQ:CDTX) issued its quarterly earnings data on Thursday. The biotechnology company reported ($0.80) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.70) by ($0.10), Bloomberg Earnings reports.

Top 5 Medical Stocks To Own For 2019: American Electric Power Company, Inc.(AEP)

Advisors’ Opinion:

  • [By Chris Lange]

    American Electric Power Company, Inc. (NYSE: AEP) shares were recently up 2.5% at $64.93, with a 52-week range of $62.69 to $78.07 and a consensus price target of $74.00.

  • [By Reuben Gregg Brewer]

    On the surface, American Electric Power Company, Inc. (NYSE:AEP) is a pretty simple business to understand — it generates and distributes electricity. But when you dig under the surface a little, you start to see that its business has changed materially in recent years. More important, AEP is now positioned to take advantage of industry shifts taking place in the power sector. Here’s how AEP makes most of its money and why its prospects for slow and steady growth are so strong.

  • [By ]

    Consolidated Edison (ED) : “Mr. Ed is a buy, buy, buy. I also like American Electric Power (AEP) .”

    Clorox (CLX) : “Clorox is caught up in the Treasury yield vortex. I say you buy some and when it comes down you buy more.”

  • [By Logan Wallace]

    Stephens Inc. AR decreased its position in American Electric Power (NYSE:AEP) by 10.9% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 38,738 shares of the utilities provider’s stock after selling 4,742 shares during the quarter. Stephens Inc. AR’s holdings in American Electric Power were worth $2,657,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 5 Medical Stocks To Own For 2019: ESSA Pharma Inc.(EPIX)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Medical Stocks To Own For 2019: Haverty Furniture Companies, Inc.(HVT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Havertys (NYSE:HVT) – Stock analysts at KeyCorp dropped their Q2 2018 earnings per share estimates for Havertys in a research report issued on Wednesday, May 2nd. KeyCorp analyst B. Thomas now anticipates that the company will post earnings per share of $0.29 for the quarter, down from their previous forecast of $0.31. KeyCorp also issued estimates for Havertys’ Q3 2018 earnings at $0.39 EPS and Q4 2018 earnings at $0.45 EPS.